Exploring the Relationship Between Anastasis and Mitochondrial ROS-Mediated Ferroptosis in Metastatic Chemoresistant Cancers: A Call for Investigation
July 2024
in “
Frontiers in Immunology
”
Studysummary This review explores the complex relationships between ferroptosis, anastasis, and chemoresistance in cancer therapy, highlighting the potential of combining ferroptosis with immunotherapy to overcome resistance and improve personalized cancer treatments.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document explores the complex relationship between anastasis, mitochondrial ROS-mediated ferroptosis, and chemoresistance in metastatic cancers. It highlights the potential of targeting molecular pathways involved in anastasis to enhance the efficacy of ferroptosis inducers, which could help overcome chemoresistance in cancer therapy. The study emphasizes the importance of understanding the interplay between DNA damage response proteins, metabolic changes, and redox states during anastasis and ferroptosis. This understanding could lead to the development of combinatorial therapeutic regimens that inhibit anastasis while inducing ferroptosis, reducing cancer cell resistance to chemotherapy. The review also discusses the role of lipid metabolism, particularly involving GPX4 and System Xc-, in ferroptosis and cancer progression, and suggests that integrating anastasis and ferroptosis into strategies targeting chemoresistance, along with exploring synergy with immunotherapy, could advance treatment for chemoresistant cancers.
